A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH

NCT03985423 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Hemophagocytic Lymphohistiocytoses

Interventions

DRUG: Emapalumab-Lzsg

Sponsor

Swedish Orphan Biovitrum

Collaborators

[object Object]